COVID-19 ELISA IgG / IgM DIATHEVA kit
Diatheva has developed a range of assays based on ELISA technology for the semiquantitative detection of specific IgG and IgM immunoglobulins for SARS-CoV-2
The kits use the virus nucleocapsid protein as a diagnostic marker.
Principle of the assay
COVID-19 ELISA IgG DIATHEVA kit and COVID-19 ELISA IgM DIATHEVA kit are Immunoenzymatic essay (ELISA) for the determination of IgG and IgM antibodies to the COVID-19 coronavirus Nucleocapsid (N) antigen from plasma and serum.
Selling Points
Reliability: the kits provide positive and negative controls
Turn around time is less than 2 hours and 30 minutes
Convenience: all reagents are ready to use providing continuity, stability and a long shelf life
High sensitivity and specificity
COVID-19 ELISA IgG DIATHEVA kit
Diagnostic sensitivity: 98%
Diagnostic specificity: 98%
COVID-19 ELISA IgM DIATHEVA kit
Diagnostic sensitivity: 97.52%
Diagnostic specificity: 99.6%
Workflow
1. Sample collection
Serum or plasma sampling
2. Execution of the ELISA analysis
(manual or automatic mode)
3. Reading of the results
Workflow
1. Sample collection
Serum or plasma sampling
2. Execution of the ELISA analysis
(manual or automatic mode)